In support of these findings, a previous study measured serum GDF-15 concentrations in patients (in an Asian population) with both T2DM and NAFLD and showed that GDF-15 concentrations were higher in those with T2DM and advanced liver fibrosis [13]. The gene discussed is GDF15; the disease is metabolic dysfunction-associated steatotic liver disease.